NEW YORK, NY / ACCESSWIRE / June 25, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Cerus Corporation (NASDAQ: CERS), a biomedical products company focused in the field of blood transfusion safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma.
The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites that may be present in donated blood.
CERS full pipeline and an upward revision in company guidance, full report READ MORE
Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/cerus-corporation/
Global demand for platelet kits continued to be robust with first quarter platelet kit sales volumes more than doubling compared to the prior year, led by increased shipments in France and the U.S.
In the U.S., blood centers are continuing to increase production of INTERCEPT platelets to meet the ever-growing hospital demand for pathogen-reduced platelets. In France, the company gained additional regulatory approvals on its dual storage processing set for INTERCEPT platelets and shelf-life extension from five to seven days which should allow for increased blood center operational efficiencies and lower product wastage.
Details on Q1 financial data, BARDA funding, and recent company highlights READ MORE
Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/cerus-corporation/
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source
